Global Biopharmaceutical Manufacturing Market Price Trends, Size, Share and Forecast 2017-2022

1

Global Biopharmaceutical Manufacturing Market
Report 2017-2021
Copyright IMARC. All Rights Reserved
2
About IMARC Group
Report Description
IMARC is a leading advisor on management
strategy and market research worldwide. We
partner with clients in all sectors and regions
to identify their highest-value opportunities,
address their most critical challenges, and
transform their businesses. IMARCs information
products include major market, scientific,
economic and technological developments for
business leaders in pharmaceutical, industrial,
and high technology organizations. Market
forecasts and industry analysis for
biotechnology, advanced materials,
pharmaceuticals, food and beverage, travel and
tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Biopharmaceutical Manufacturing Market
Technological Advancements and Rise in
Outsourcing Activities Stimulating Growth The
global biopharmaceutical manufacturing industry
has witnessed a balanced growth over the past
several years, owing to the increasing popularity
of biopharmaceuticals along with capacity
expansions, advancements in technology and the
emerging trend of outsourcing activities. The
latest report by IMARC Group titled, Global
Biopharmaceutical Manufacturing Market Report
2017-2021, finds that the global
biopharmaceutical manufacturing capacity has
grown at a CAGR of more than 4 during 2009-2016,
reaching a volume of around 4.5 Million Litres in
2016. Biopharmaceuticals currently represent the
fastest growing segment in the global
pharmaceuticals market on account of their
various health benefits. The high returns
associated with their production has also
prompted a number of companies to develop and
manufacture biopharmaceutical drugs. Moreover,
the emergence of biosimilars coupled with
capacity expansions are further expected to
bolster the market growth. According to the
report, the global biopharmaceutical
manufacturing market is projected to reach a
volume of 6.6 Million Litres by 2021. Highlights
of the Global Biopharmaceutical Manufacturing
Market
4
Report Description and Highlights
Report Description

• Continuous improvements in technology and growth
  in outsourcing activities remain the major
  drivers.
• Mammalian cell culture represents the largest
  category, accounting for the majority of
  production volume.
• North America dominates the market, accounting
  for nearly half of the market share.
• One of the major trends in the market is the
  continuous improvement in technology aimed at
  increasing productivity. Manufacturers are
  focusing on processes such as continuous
  bioprocessing and the use of single-use or
  disposable devices so as to increase the yield.
  Moreover, owing to the significant cost savings
  and effectiveness as well as innovation and
  specific capabilities offered by the contract
  manufacturers, a number of companies are
  outsourcing various production activities to
  them. The contract manufacturers carry out
  activities ranging from the analytical testing of
  bioassays to testing the cell line stability and
  product characterisation. A large number of
  contract manufacturers are based in emerging
  regions such China and India which are
  progressively becoming a major destination for
  outsourcing.
• On the basis of the cell culture, the market has
  been divided into mammalian and microbial cell
  cultures. Mammalian cell culture currently
  represents the largest category, accounting for
  the majority of the production volume. This can
  be attributed to the large number of drugs which
  are
• Read full report _at_ http//www.imarcgroup.com/globa
  l-biopharmaceutical-manufacturing-market

5
Report Description and Highlights
Report Description

• made using mammalian cell cultivation. On the
  basis of class, the market has been segmented
  into recombinant proteins, monoclonal antibodies,
  interferons, erythropoietin, granulocyte
  colony-stimulating factor (G-CSF), recombinant
  human insulin, vaccines and human growth hormones
  (HGH). On the basis of region, North America
  currently represents the largest market,
  accounting for nearly half of the total market
  share. Some of the key players operating in the
  market include Biogen Idec, Roche, Eli Lilly,
  Amgen, Merck Co., Novo Nordisk, Pfizer, AbbVie,
  Sanofi S.A and Johnson Johnson.
• The report by IMARC Group has examined the global
  biopharmaceutical manufacturing market on the
  basis of
• Cell Culture
• Mammalian Cell Culture
• Microbial Cell Culture
• Class
• Monoclonal Antibodies
• Recombinant Proteins
• Interferon
• Granulocyte Colony-Stimulating Factor (G-CSF)
• Erythropoietin

6
Report Description and Highlights
Report Description

• Recombinant Human Insulin
• Vaccines
• Human Growth Hormones
• Region
• North America
• Europe
• Asia
• Major Manufacturers
• Roche
• Amgen
• Novo Nordisk
• AbbVie
• Sanofi SA
• Johnson Johnson
• Pfizer
• Merck Co.
• Ely Lilly

7
Report Description and Highlights
Report Description
Request Sample of the Report http//www.imarcgro
up.com/request?typereportid724flagB Browse
Related Reports   US Generic Injectables Market
_at_ http//www.imarcgroup.com/us-generic-injectables
-market Global Anti-Aging Market _at_
http//www.imarcgroup.com/anti-aging-market
8
Report Description and Highlights
Report Description

2017 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
9

Contact Us